Thus, advances in developing treatment modalities for common hyperkinetic and hypokinetic movement disorders, such as HD and PD,1, 5 might be conducive to achieving effective treatment of the rare PDE1B disease, and vice versa. The gene discussed is PDE1B; the disease is movement disorder.